XML 34 R23.htm IDEA: XBRL DOCUMENT v3.19.1
Stock-Based Compensation Plans
3 Months Ended
Mar. 31, 2019
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Stock-Based Compensation Plans
NOTE 14 – STOCK-BASED COMPENSATION PLANS
The Company grants stock options and stock equivalent units (“SEUs”) from time to time as a long-term performance incentive. In certain cases the grants are subject to performance conditions such as the Company’s stock price. Where performance conditions apply the Monte Carlo simulation model is used to determine the fair values. Otherwise the Black-Scholes model is used to determine the fair values.
 
Stock option plans
The following table summarizes the transactions of the Company’s stock option plans for the three months ended March 31, 2019:
 
 
 
Number of

Options
 
 
Weighted

Average

Exercise

Price
 
 
Weighted

Average

Grant-Date

Fair Value
 
Outstanding at December 31, 2018
 
 
545,249
 
 
$
32.46
 
 
$
36.06
 
Granted - at discount
 
 
67,230
 
 
$
0.00
 
 
$
71.54
 
              - at market value
 
 
12,539
 
 
$
81.07
 
 
$
22.69
 
Exercised
 
 
(70,632
)
 
$
13.78
 
 
$
27.78
 
Forfeited
 
 
(1,584
)
 
$
62.39
 
 
$
26.57
 
Outstanding at March 31, 2019
 
 
552,802
 
 
$
31.92
 
 
$
41.16
 
At March 31, 2019, there were 45,170 stock options that were exercisable, of which 6,592 had performance conditions attached.
The stock option compensation cost for the first three months of 2019 was $1.6 million (first three months of 2018 – $0.8 million). The total intrinsic value of options exercised in the first three months of 2019 was $2.1 million (first three months of 2018 – $1.9 million).
The total compensation cost related to non-vested stock options not yet recognized at March 31, 2019 was $14.1 million and this cost is expected to be recognized over the weighted-average period of 2.32 years.
Stock equivalent units
The following table summarizes the transactions of the Company’s SEUs for the three months ended March 31, 2019:
 
 
 
 
 
 
 
 
 
 
 
 
 
Number

of SEUs
 
 
Weighted

Average

Exercise

Price
 
 
Weighted

Average

Grant-Date

Fair Value
 
Outstanding at December 31, 2018
 
 
418,936
 
 
$
3.47
 
 
$
52.45
 
Granted - at discount
 
 
119,315
 
 
$
0.00
 
 
$
71.70
 
              - at market value
 
 
4,359
 
 
$
81.07
 
 
$
22.69
 
Exercised
 
 
(118,772
)
 
$
2.42
 
 
$
47.35
 
Forfeited
 
 
(750
)
 
$
0.00
 
 
$
51.05
 
Outstanding at March 31, 2019
 
 
423,088
 
 
$
3.59
 
 
$
59.01
 
At March 31, 2019, there were 41,312 SEUs that are exercisable, of which 37,920 had performance conditions attached.
The charges for SEUs are spread over the life of the award subject to a revaluation to fair value each quarter. The revaluation may result in a charge or a credit to the income statement in the quarter dependent upon our share price and other performance criteria.
 
The SEU compensation cost for the first three months of 2019 was $7.5 million (first three months of 2018 – $1.2 million). The total intrinsic value of SEUs exercised in the first three months of 2019 was $6.2 million (first three months of 2018 - $1.6 million).
The weighted-average remaining vesting period of non-vested SEUs is 2.39 years.